Find Cloperastine Fendizoate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 85187-37-7, Hustazol, Nitossil, Sekin, Cloperastine fendizoate [jan], Einecs 286-126-9
Molecular Formula
C40H38ClNO5
Molecular Weight
648.2  g/mol
InChI Key
PXZFKAKWSHBDCP-UHFFFAOYSA-N
FDA UNII
2M105305SU

Cloperastine Fendizoate
1 2D Structure

Cloperastine Fendizoate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine;2-(4-hydroxy-3-phenylbenzoyl)benzoic acid
2.1.2 InChI
InChI=1S/C20H24ClNO.C20H14O4/c21-19-11-9-18(10-12-19)20(17-7-3-1-4-8-17)23-16-15-22-13-5-2-6-14-22;21-18-11-10-14(12-17(18)13-6-2-1-3-7-13)19(22)15-8-4-5-9-16(15)20(23)24/h1,3-4,7-12,20H,2,5-6,13-16H2;1-12,21H,(H,23,24)
2.1.3 InChI Key
PXZFKAKWSHBDCP-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
2M105305SU
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 85187-37-7

2. Hustazol

3. Nitossil

4. Sekin

5. Cloperastine Fendizoate [jan]

6. Einecs 286-126-9

7. Hustazol (tn)

8. Unii-2m105305su

9. 2m105305su

10. 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine;2-(4-hydroxy-3-phenylbenzoyl)benzoic Acid

11. Chebi:31419

12. Cloperastine Fendizoate [mart.]

13. Cloperastine Fendizoate [who-dd]

14. O-((2'-hydroxy(1,1'-biphenyl)-4-yl)carbonyl)benzoic Acid, Compoundwith 1-(2-(4-chlorobenzhydryloxy)ethyl)piperidine (1:1)

15. Cloperastine Fendizoate (jan)

16. Cloperastine Fendizoate (mart.)

17. 1-(2-((4-chlorophenyl)(phenyl)methoxy)ethyl)piperidine 2-(6-hydroxy-[1,1'-biphenyl]-3-carbonyl)benzoate

18. 1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-hydroxy[1,1'-biphenyl]-3-yl)carbonyl]benzoate Piperidine

19. Cloperastinefendizoate

20. Cloperastine Fendizoate (jp18)

21. Dtxsid001005645

22. Hy-b2179

23. Mfcd01661515

24. Akos040740750

25. Cs-7697

26. Bs-44741

27. Da-51971

28. Sy317590

29. D01569

30. E74488

31. J-520104

32. Q27254909

33. 1-[2-[(4-chlorophenyl)(phenyl)methoxy]ethyl]piperidine 2-(6-hydroxybiphenyl-3-carbonyl)benzoate

34. 2-(6-hydroxy[1,1'-biphenyl]-3-carbonyl)benzoic Acid--1-{2-[(4-chlorophenyl)(phenyl)methoxy]ethyl}piperidine (1/1)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 648.2 g/mol
Molecular Formula C40H38ClNO5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count10
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area87.1
Heavy Atom Count47
Formal Charge0
Complexity772
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty